Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Research|April 6, 2006
Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tractMelanie H Kucherlapati, Andrew A Nguyen, Roderick T Bronson, et al.American Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Optical imaging with a novel cathepsin-activatable probe for enhanced detection of colorectal cancerShadi A Esfahani, Pedram Heidari, Melanie H Kucherlapati, et al.Plos One|August 13, 2013
Genotype directed therapy in murine mismatch repair deficient tumorsMelanie H Kucherlapati, Shadi Esfahani, Peiman Habibollahi, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2011
Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse modelMichael A McIlhatton, Jessica Tyler, Laura A Kerepesi, et al.Proceedings of the National Academy of Sciences of the United States of America|October 4, 2008
Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colonMelanie H Kucherlapati, Kan Yang, Kunhua Fan, et al.Gut|November 28, 2014
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre miceBenedikt Kortüm, Christoph Campregher, Michaela Lang, et al.Human Molecular Genetics|October 14, 2010
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human diseaseDavid A McDonald, Robert Shenkar, Changbin Shi, et al.Plos One|September 13, 2012
Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in miceMarina Kovalenko, Ella Dragileva, Jason St Claire, et al.Gastroenterology|November 26, 2009
An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agentsMelanie H Kucherlapati, Kyeryoung Lee, Andrew A Nguyen, et al.Pageof 1